NTLA
Intellia Therapeutics Inc.
$17.26
+$1.67(+10.71%)
58
Overall
--
Value
58
Tech
--
Quality
Market Cap
$1.67B
Volume
8.88M
52W Range
$5.90 - $21.94
Target Price
$32.78
EPS Estimates Overview
| Current Quarter | $-1.01 | Next Quarter | $-0.99 |
| Current Year | $-4.09 | Next Year | $-3.98 |
| QoQ Growth | +2.0% | YoY Growth | +2.7% |
| 3Y EPS CAGR | +0.0% | Target Price | $32.78 |
| Consensus | Buy | Upside | +89.9% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NTLA | $17.26 | +10.7% | 8.88M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Intellia Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW